trial · primary record
Selexipag
Hypertension, Pulmonary
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 138 |
| Primary completion | 2027-10-01 |
| Primary endpoint | Double-blind Period: Time to Disease Progression |
| Registry ID | NCT04175600 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:07.396Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04175600
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.